PRLN
PARACELSIAN ANNOUNCES MAJOR INTERNET INITIATIVE
ITHACA, N.Y., Oct 13, 1999 /PRNewswire via COMTEX/ -- Paracelsian,
Inc. (OTC Bulletin Board: PRLN) ITHACA, N.Y., announced today an
initiative to develop a world-leading internet portal site dedicated to
health empowerment through a unique Chinese-American health exchange.
Dr. T. Colin Campbell, a world-renowned Professor of Nutrition at
Cornell University, has agreed to lead Paracelsian's internet
initiative. Paracelsian (http://www.paracelsian.com) further announced
ongoing discussions with two major Chinese health care agencies, and
with BioSignia, Inc., to develop this portal site. Paracelsian
anticipates the creation of a subsidiary devoted to this internet
initiative, with Dr. Campbell as Chairman, President and Chief
Executive Officer.
This internet initiative will combine the best of Chinese medical
practice with the best of Western practice to create new opportunities
for information on health and disease prevention. The expanded site
will combine the latest nutrition information developed in recent years
(http://www.newcenturynutrition.com) with the health assessment
technology of BioSignia (http://www.knowyournumber.com) and a wealth of
health information and health products from China
(http://www.china-med.net; tcmpharmacy.com).
"Dr. Campbell is the person most qualified to lead this initiative,"
said Bernie Landes, President and CEO of Paracelsian. "We believe that
this will provide Dr. Campbell with the ideal forum for continuing his
lifelong mission of nutrition research and teaching. We further believe
that this new structure will enable Paracelsian to benefit most fully
from Dr. Campbell's knowledge, and his extensive network of
relationships with Chinese scientists and governmental agencies,"
concluded Mr. Landes.
Dr. Campbell has been the Principal Investigator of the award winning,
nationwide study in China of diet, lifestyle and disease associations.
This investigation has been directed from Cornell, in collaboration
with Chinese government academies and the University of Oxford
(England). During nearly two decades of collaboration with his Chinese
and British colleagues, Dr. Campbell has achieved a mastery of the
wealth of Chinese information centering on health maintenance and
disease prevention.
"There is so much to share, so much to learn, when these two vastly
rich but different bodies of medical information in China and the West
are compared. It is now time to take seriously, for example, the
evidence before us showing the ability of dietary and lifestyle
practices to maintain health and to prevent disease," says Campbell.
"We now know how to improve health, to cut health care costs, and to
share information for the benefit of all. And it is our long
collaboration and strong background in science-based evaluation of
health that will give to this new company a unique opportunity to make
this happen," concluded Dr. Campbell.
BioSignia, Inc. (http://www.biosignia.com) will also play a role in
Paracelsian's internet strategy. BioSignia has developed unique
internet- based algorithms of health assessment, economic cost
modeling, and medical decision making; these can be used by
individuals, physicians and organizations. Dr. Timothy Smith, CEO of
BioSignia, has 25 years of experience in the clinical lab industry, and
is leading the effort to develop assessment and prediction tools that
offer unique opportunities for individuals to take increasing
responsibility for their own health.
Paracelsian is a unique biotechnology company whose business centers on
the development and application of functional bioassays. These assays
are the basis of its BioFIT(TM) Quality Assurance program for herbs,
botanicals and other dietary supplements, are also used in the
development of dietary supplements, OTC and pharmaceutical products,
and are used in monitoring environmental toxins and identifying
carcinogens. The company is also increasingly involved in E-commerce
through its Internet business that leverages its unique relationships
in China to provide proprietary content and a variety of research
services.
Notice: This news release may contain forward-looking statements.
Investors are cautioned that such forward-looking statements involve
risks and uncertainties, including but not limited to, the results of
research and development efforts, the effect of regulation by the
United States Food and Drug Administration and other agencies, the
impact of competitive products, product development, commercialization
and technological difficulties, and other risks detailed in the
Company's periodic reports filed with the Securities and Exchange
Commission.
No forward-looking statement is a guarantee of future results or
events, and one should avoid placing undue reliance on such statements.
SOURCE Paracelsian, Inc.
(C) 1999 PR Newswire. All rights reserved.
prnewswire.com
CONTACT: Bernie Landes, CEO and COB of Paracelsian, Inc., 607-257-4224
WEB PAGE: paracelsian.com
GEOGRAPHY: New York
INDUSTRY CODE: BIO
MLM
SUBJECT CODE: OTC
|
